[find our papers on PubMed]
* co-first author; ¶ co-corresponding author

2022 (1)

Advancing discovery of risk-altering variants for complex diseases by functionally informed fine-mapping
Chen Y, Clark A and Yu H. Neuron 2022 110(6):905-907..

2021 (1)

A 3D structural SARS-CoV-2–human interactome to explore genetic and drug perturbations
Wierbowski SD, Liang S, Liui Y, Chen Y, Gupta S, Andre NM, Lipkin SM, Whittaker GR, Yu H. Nature Methods 2021 December 18, 1477–1488. .
First published on bioRxiv 2020 (DOI:10.1101/2020.10.13.308676)

2013 (1)

Integrative annotation of variants from 1,092 humans: application to cancer genomics
Khurana E, Fu Y, Colonna V, Mu XJ, Kang HM, Lappalainen T, Sboner A, Lochovsky L, Chen J, Harmanci A, Das J, Abyzov A, Balasubramanian S, Beal K, Chakravarty D, Challis D, Chen Y, Clarke D, Clarke L, Cunningham F, Evani US, Flicek P, Fragoza R, Garrison E, Gibbs R, Gümüş ZH, Herrero J, Kitabayashi N, Kong Y, Lage K, Liluashvili V, Lipkin S, MacArthur DG, Marth G, Muzny D, Pers TH, Ritchi G, Rosenfeld JA, Sisu C, Wei X, Wilson M, Xue Y, Yu F, 1000 Genomes Project Consortium, Dermitzakis ET, Yu H, Rubin MA, Tyler-Smith C, Gerstein M. Science 2013 Oct 342 (6154), 1235587.
Highlighted as "Research Highlights" in Nature, 2013, 502: 144